Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Salomon Website

David S. Salomon, Ph.D.

Selected Publications

1)  Terry S, Allory Y, Maille P, Ploussard G, Pimple C, Destouches D, Huet E, Kheuang L, Soyeux P, Sirab N, Esgueva R, Beltran H, Bianco C, de la Taille A, Salomon D, Vacherot F.
Role and prognostic value of Cripto-1 in prostate cancer.
J. Clin. Invest. 2013.
In Press. [Journal]
2)  Yan T, Mizutani A, Chen L, Takaki M, Hiramoto Y, Matsuda S, Shigehiro T, Kasai T, Kudoh T, Murakami H, Masuda J, Hendrix M, Strizzi L, Salomon D, Fu L, Seno M.
Characterization of cancer stem-like cells from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles.
J. Cancer. 2014.
In Press. [Journal]
3)  Matsuda S, Yan T, Mizutani A, Sota T, Hiramoto Y, Prieto-Vila M, Chen L, Satoh A, Kudoh T, Kasai T, Murakami H, Fu L, Salomon DS, Seno M.
Cancer stem cells maintain a hierarchy of differentiation by creating their niche.
Int. J. Cancer. 135: 27-36, 2014.
4)  Francescangeli F, Contavalli P, Gambara G, De Angelis M, Baiocchi M, Pagliuca A, Fiorenzano A, Todaro M, Stassi G, Watanabe K, Castro N, Salomon D, De Maria R, Minchiotti G, Zeuner A.
Transient stemness states in human colon cancer are controlled by Cripto-1.
EMBO J. 2014.
In Press. [Journal]
5)  Park KS, Raffeld M, Moon YW, Xi L, Bianco C, Pham T, Lee LC, Mitsudomi T, Yatabe Y, Okamoto I, Subramaniam D, Mok T, Rosell R, Luo J, Salomon DS, Wang Y, Giaccone G.
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance.
J. Clin. Invest. 2014.
6)  Chen L, Mizutani A, Kasai T, Yan T, Jin G, Vaidyanath A, El-Aarag BY, Liu Y, Kudoh T, Salomon DS, Fu L, Seno M.
Mouse induced pluripotent stem cell microenvironment generates epithelial-mesenchymal transition in mouse Lewis lung cancer cells.
Am J Cancer Res. 4: 80-8, 2014.
7)  Mertins SD, Scudiero DA, Hollingshead MG, Divelbiss RD, Alley MC, Monks A, Covell DG, Hite KM, Salomon DS, Niederhuber JE.
A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept.
PLoS ONE. 8: e57099, 2013.
8)  Nagaoka T, Karasawa H, Turbyville T, Rangel MC, Castro NP, Gonzales M, Baker A, Seno M, Lockett S, Greer YE, Rubin JS, Salomon DS, Bianco C.
Cripto-1 enhances the canonical Wnt/ß-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Cell. Signal. 25: 178-89, 2013.
9)  Boulanger CA, Bruno RD, Mack DL, Gonzales M, Castro NP, Salomon DS, Smith GH.
Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment.
PLoS ONE. 8: e62019, 2013.
10)  Jin G, Mizutani A, Fukuda T, Otani T, Yan T, Prieto Vila M, Murakami H, Kudoh T, Hirohata S, Kasai T, Salomon DS, Seno M.
Eosinophil cationic protein enhances stabilization of ß-catenin during cardiomyocyte differentiation in P19CL6 embryonal carcinoma cells.
Mol. Biol. Rep. 40: 3165-71, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 6/17/2014.